4.2 Article

Circulating miR-126 as a Potential Non-invasive Biomarker for Intracra-nial Aneurysmal Rupture: A Pilot Study

Journal

CURRENT NEUROVASCULAR RESEARCH
Volume 18, Issue 5, Pages 525-534

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1567202619666211217142116

Keywords

miR-126; intracranial aneurysm; aSAH; diagnosis; prediction; biomarker

Ask authors/readers for more resources

The study measured circulating miR-126 levels at different time points, finding higher levels in UIAs patients compared to healthy controls, and a substantial increase from day 1 to day 7 in aSAH patients, peaking on day 7. miR-126 showed high diagnostic value and could serve as a biomarker for detecting IAs and preventing high-risk ruptures.
Aim: Intracranial aneurysms (IAs) are characterized by abnormal dilation and thinning of the cerebral vessels wall, leading to rupture and life-threatening aneurysmal subarachnoid hemorrhage (aSAH) condition. This dictates the need to find new biomarkers that predict the presence of IAs and the risk of their rupture. The aim of this study was to measure circulating miR-126 at various time points post-aSAH to identify the timing of peak levels. Methods: Plasma samples from 62 patients with unruptured IAs (UIAs), 80 patients with aSAH at various time points (1, 3, 7, and 14 days post-event), and 47 healthy control were collected and subjected to qRT-PCR analyses for the expression levels of circulating miR-126. ROC curve and AUC were used to evaluate the diagnostic value of circulating miR-126. Results: The expression levels of circulating miR-126 were increased in patients with UIAs than in the healthy control. Furthermore, the expression levels of circulating miR-126 rose substantially from day 1 to day 7, but with a moderate decrease from day 7 to day 14 in plasma of patients with aSAH. The peak was observed on day 7. The AUC for miR-126 was 0.75, 0.75, 0.82, 0.87, and 0.79, respectively, and demonstrated that circulating miR-126 displayed considerable accuracy in discriminating plasma of patients with UIAs and patients after aSAH at various time points from a healthy control. Conclusion: Our results indicated that circulating miR-126 in plasma samples could be served as a potential non-invasive biomarker in IAs detection and prevention IAs with a high risk of rupture.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available